Targeting a coronavirus ion channel could yield new COVID-19 drugs

The genome of the SARS-CoV-2 virus encodes 29 proteins, one of which is an ion channel called E. This channel, which transports protons and calcium ions, induces infected cells to launch an inflammatory response that damages tissues and contributes to the symptoms of COVID-19. MIT chemists have now discovered the structure of the “open” state of this channel, which allows ions to flow through.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news